Individualized Dosing of Selexipag Based on Tolerability in the GRIPHON Study Shows Consistent Efficacy and Safety in Patients With Pulmonary Arterial Hypertension (PAH)

Details

Language :

English

ISSN :

00123692 and 19313543

Volume :

148

Issue :

4, Number 4 Supplement 1

Database :

Supplemental Index

Journal :

Chest

Publication Type :

Periodical

Accession number :

ejs38032750

Full Text :

https://doi.org/10.1378/chest.2256760